Cite
HARVARD Citation
Olivieri, M. et al. (2022). Analysis of pooled real-world data from Germany, Italy, and the United States of rVIII-SingleChain compared with standard- and long-acting FVIII products for prophylaxis of hemophilia A. Current medical research and opinion. pp. 1133-1139. [Online].